Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patency Rate”

Showing 20 of 0 results

Very early researchUnknownNCT02622750
What this trial is testing

Triple-branch Stent Graft Placement and Total-arch Replacement for the Treatment of Acute DeBakey I Aortic Dissection

Who this might be right for
Acute Aortic Dissection
Liang-Wan Chen MD 90
Large-scale testing (Phase 3)UnknownNCT01063491
What this trial is testing

Cardiac CAtheterization for Bypass Graft Patency Rate Optimization: the CABG-PRO Randomized-controlled Pilot Study

Who this might be right for
Coronary Artery Bypass Graft Surgery
North Texas Veterans Healthcare System 170
Testing effectiveness (Phase 2)Study completedNCT00532129
What this trial is testing

MabThera (Rituximab) Plus Chlorambucil in Participants With Chronic Lymphocytic Leukemia.

Who this might be right for
Lymphocytic Leukemia, Chronic
Hoffmann-La Roche 100
Not applicableStudy completedNCT02104141
What this trial is testing

Retrospective/Prospective Data Collection on the LDR ROIA Interbody Fusion Device With VerteBRIDGE Plating

Who this might be right for
Degenerative Disc Disease
LDR Spine USA 51
Not applicableStudy completedNCT05027542
What this trial is testing

Comparison of Distally Based Sural Artery and Supramalleolar Flap for Coverage of Dorsum of Foot and Ankle Defects

Who this might be right for
Open Wound of Lower Limb
Abeer Musaddiq 53
Testing effectiveness (Phase 2)Study completedNCT05114746
What this trial is testing

Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer in Japan

Who this might be right for
Prostate Cancer
Novartis Pharmaceuticals 94
Testing effectiveness (Phase 2)Study completedNCT00165620
What this trial is testing

A Randomized, Open, Parallel, Optimal Injection Rate-Finding Study for E7337 in Dynamic CT of the Liver in Patients With Liver Disease

Who this might be right for
Lesion
Eisai Limited
Testing effectiveness (Phase 2)Temporarily pausedNCT02008019
What this trial is testing

A Phase II Study of EVEROLIMUS in Patients With Primary or Relapsed Chondrosarcomas

Who this might be right for
Chondrosarcoma
Centre Leon Berard 57
Not applicableUnknownNCT04581161
What this trial is testing

Proportional Open Ventilation (POV) Device and Its Efficacy in Managing Acute Respiratory Failure in COVID-19 Patients

Who this might be right for
Acute Respiratory FailureCovid19
Hill-Rom 10
Not applicableStudy completedNCT05236751
What this trial is testing

Hyperglycemia in Neurosurgery

Who this might be right for
HyperglycemiaPostoperative Infection
Boston Medical Center 52
Not applicableStudy completedNCT04168775
What this trial is testing

Peak Inspiratory Flow Rates in Patients With COPD

Who this might be right for
COPD
University of North Carolina, Chapel Hill 80
Early research (Phase 1)Study completedNCT01651312
What this trial is testing

Assess the Systemic Pharmacokinetics, Metabolism and Excretion Routes of YM178 in Man, After Administration of Radio-labeled YM178

Who this might be right for
Metabolic Processes
Astellas Pharma Europe B.V. 4
Not applicableStudy completedNCT03747861
What this trial is testing

Measuring Accuracy of Wristband for Registration of ECG RR-Intervals for One Hand, SenceBand in Comparison to Holter

Who this might be right for
HRV
Planexta, Inc 59
Post-approval studies (Phase 4)Study completedNCT00171496
What this trial is testing

Evaluation of Cyclosporine Microemulsion and Tacrolimus on the Rate of New Onset Diabetes Mellitus in Kidney Transplantation Recipients

Who this might be right for
Kidney Transplant
Novartis 693
Testing effectiveness (Phase 2)Study completedNCT00532233
What this trial is testing

SD, IL-13 Production Rate in IPF

Who this might be right for
Idiopathic Pulmonary Fibrosis
Novartis Pharmaceuticals 52
Post-approval studies (Phase 4)Study completedNCT04196309
What this trial is testing

Effect of LOW-molecular-weight Heparin in Reducing Radial Artery Occlusion Rate After Transradial Coronary Catheterization

Who this might be right for
Arterial Occlusion
AHEPA University Hospital 60
Testing effectiveness (Phase 2)Ended earlyNCT04671901
What this trial is testing

Romiplostim to Prevent Low Platelet Counts in Children and Young Adults Receiving Chemotherapy for Solid Tumors

Who this might be right for
Solid TumorSolid Tumor, ChildhoodSolid Carcinoma
Memorial Sloan Kettering Cancer Center 2
Large-scale testing (Phase 3)Ended earlyNCT05171075
What this trial is testing

A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE

Who this might be right for
Venous ThromboembolismDeep Venous ThrombosisPulmonary Embolism
Anthos Therapeutics, Inc. 417
Testing effectiveness (Phase 2)Ended earlyNCT00620100
What this trial is testing

To Determine the Objective Response Rate of 4 Cycles of Docetaxel + Anthracycline (Epirubicin or Doxorubicine) Followed by 4 Cycles of Docetaxel Single Agent

Who this might be right for
Breast Neoplasms
Sanofi 2
Testing effectiveness (Phase 2)Study completedNCT05670106
What this trial is testing

Evaluate the Efficacy, Safety, Pharmacokinetics and Dosimetry of [177Lu]Lu-PSMA-617 in Chinese Adult Male Patients With Progressive PSMA-Positive mCRPC

Who this might be right for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Novartis Pharmaceuticals 62
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation